-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
-
US races to secure rare earths to rebuild depleted arsenal
-
Matthew Perry drug middleman jailed for two years
-
Warsh confirmed as Fed chair as central bank faces Trump assault
-
Kohli ton powers Bengaluru past Kolkata, to top of IPL
-
Ex-Nicaragua guerrilla believes Ortega-Murillo days numbered
-
Berlin launches scheme to swap trash for treats
-
Sarah Taylor named England men's fielding coach
-
No plans for PGA outside USA or moving off May date
-
US Senate backs Trump on Iran war despite deadline lapse
-
Key urges 'world-class' bowler Robinson to make England recall count
-
From Black Death to Covid, ships have long hosted outbreaks
-
Furyk wants long-term US Ryder blueprint, maybe role for Tiger
-
McIlroy back on course on eve of PGA despite blister
-
Eulalio seizes control of drenched Giro d'Italia
-
New trial ordered for US lawyer convicted of murdering wife, son
-
Stocks rise ahead of US-China summit
-
US wholesale prices jump 6.0% year-on-year in April, highest since 2022
-
Nations drawing down oil stocks at record pace: IEA
-
Carrick on brink of permanent Man Utd job: reports
-
Strong US economy's resilience to shocks tested by Iran war
-
Italy cheers UK's Catherine on first foreign visit since cancer diagnosis
Zuckerbergs put AI at heart of pledge to cure diseases
The Chan Zuckerberg Initiative, a nonprofit launched by Mark Zuckerberg and his wife aimed at curing all disease, on Thursday announced it was restructuring to focus its efforts on using artificial intelligence to achieve that goal.
The philanthropic mission created in 2016 by the Meta co-founder and his spouse, Priscilla Chan, said that its scientific teams will now be centralized in an organization dubbed Biohub.
"This is a pivotal moment in science, and the future of AI-powered scientific discovery is starting to come into view," Biohub said in a blog post.
"We believe that it will be possible in the next few years to create powerful AI systems that can reason about and represent biology to accelerate science."
Biohub envisions AI helping advance ways to detect, prevent and cure diseases, according to the post.
The mission includes trying to model the human immune system, potentially opening a door to "engineering human health."
"We believe we're on the cusp of a scientific revolution in biology -- as frontier artificial intelligence and virtual biology give scientists new tools to understand life at a fundamental level," Biohub said in the post.
The first investment announced by the Zuckerbergs when the initiative debuted was for the creation of a Biohub in San Francisco where researchers, scientists and others could work to build tools to better study and understand diseases.
Shortly after it was established, the initiative bought a Canadian startup which uses AI to quickly read and comprehend scientific papers and then provide insights to researchers.
"Our multidisciplinary teams of scientists and engineers have built incredible technologies to observe, measure and program biology," Biohub said of its progress.
Meta is among the big tech firms that have been pouring billions of dollars into data centers and more in a race to lead the field of AI.
V.Dantas--PC